High-dose therapy with ropinirole in patients with Parkinson's disease

被引：0
|
作者：
M. Müngersdorf
U. Sommer
M. Sommer
H. Reichmann
机构：
[1] Department of Neurology,
[2] Technical University of Dresden,undefined
[3] Dresden,undefined
[4] and,undefined
[5] Department of Clinical Neurophysiology,undefined
[6] Center for Neurological Medicine,undefined
[7] University of Göttingen,undefined
[8] Göttingen,undefined
[9] Federal Republic of Germany,undefined
来源：
Journal of Neural Transmission | 2001年 / 108卷
关键词：
Keywords: Ropinirole; high-dose therapy; dyskinesias; motor fluctuations; dopamine agonist; Parkinson's disease.;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Ropinirole is effective as mono- and combination therapy in PD. Previous studies have used a maximal dose of 24 mg/day; the present study assesses the effect of higher doses (up to 36 mg/day) on patients with motor fluctuations. Outcome measures were changes in the motor function score of the Unified Parkinson's Disease Rating Scale, the duration of dyskinesias and reductions in levodopa dose.
引用
收藏
页码：1309 / 1317
页数：8
相关论文
共 50 条
  • [11] High-dose therapy for Hodgkin's disease
    Linch, DC
    Goldstone, AH
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (04) : 685 - 690
  • [12] The safety and efficacy of ropinirole as early therapy in elderly patients with Parkinson's disease
    Korczyn, AD
    Keens, J
    Oldham, M
    Macrae, S
    NEUROLOGY, 2000, 54 (07) : A90 - A90
  • [13] Efficacy and safety of high-dose cabergoline in Parkinson's disease
    Odin, P
    Oehlwein, C
    Storch, A
    Polzer, U
    Werner, G
    Renner, R
    Shing, M
    Ludolph, A
    Schüler, P
    ACTA NEUROLOGICA SCANDINAVICA, 2006, 113 (01): : 18 - 24
  • [14] High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias
    Storch, A
    Trenkwalder, C
    Oehlwein, C
    Winkelmann, J
    Polzer, U
    Hundemer, HP
    Schwarz, J
    PARKINSONISM & RELATED DISORDERS, 2005, 11 (06) : 393 - 398
  • [15] Evidence for association of high-dose levodopa therapy with intellectual and psychiatric complications of Parkinson's disease
    Hamza, T.
    Factor, S.
    Molho, E.
    Montimurro, J.
    Pratt, D.
    Rosen, A.
    Higgins, D.
    Payami, H.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S119 - S119
  • [16] Effects of high-dose ropinirol on sexual functions in Parkinson's disease
    Kovacs, N.
    Janszky, J.
    Nagy, F.
    JOURNAL OF NEUROLOGY, 2011, 258 : 52 - 53
  • [17] Pramipexole and ropinirole for Parkinson's disease
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1997, 39 (1014): : 109 - 110
  • [18] Pregnancy outcomes in Parkinson's disease with high-dose dopamine agonist therapy and deep brain stimulation
    Vogeler, F.
    Duwe, W.
    Ruhland, F.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2016, 76 (05)
  • [19] Side effects of ropinirole in patients with idiopathic Parkinson's disease
    Titlic, M.
    Tonkic, A.
    Jukic, I
    Lusic, I
    Dikanovic, M.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2008, 109 (06): : 273 - 275
  • [20] Ropinirole approved for Parkinson's disease
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (23) : 2655 - 2655
12345